CD274 and non-small cell lung carcinoma: At the same time, although PD-L1 expression is associated with poor prognosis in non-small-cell lung cancer (NSCLC), renal cell carcinoma (RCC), prostate cancer, and colorectal cancer, we found that PD-L1 expression is associated with better prognosis in uterine carcinosarcoma [17–19].